Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the Future

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Anatole Besarab , Stanley Frinak , Suresh Margassery , Jay B. Wish
{"title":"Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the Future","authors":"Anatole Besarab ,&nbsp;Stanley Frinak ,&nbsp;Suresh Margassery ,&nbsp;Jay B. Wish","doi":"10.1016/j.xkme.2024.100871","DOIUrl":null,"url":null,"abstract":"<div><p>This review describes the history of vascular access for hemodialysis (HD) over the past 8 decades. Reliable, repeatable vascular access for outpatient HD began in the 1960s with the Quinton-Scribner shunt. This was followed by the autologous Brecia-Cimino radial-cephalic arteriovenous fistula (AVF), which dominated HD vascular access for the next 20 years. Delayed referral and the requirement of 1.5-3 months for AVF maturation led to the development of and increasing dependence on synthetic arteriovenous grafts (AVGs) and tunneled central venous catheters, both of which have higher thrombosis and infection risks than AVFs. The use of AVGs and tunneled central venous catheters increased progressively to the point that, in 1997, the first evidence-based clinical practice guidelines for HD vascular access recommended that they only be used if a functioning AVF could not be established. Efforts to promote AVF use in the United States during the past 2 decades doubled their prevalence; however, recent practice guidelines acknowledge that not all patients receiving HD are ideally suited for an AVF. Nonetheless, improved referral for AVF placement before dialysis initiation and improved conversion of failing AVGs to AVFs may increase AVF use among patients in whom they are appropriate.</p></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590059524000827/pdfft?md5=cf69ae735b1b975e80cfe9feaf03a257&pid=1-s2.0-S2590059524000827-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524000827","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This review describes the history of vascular access for hemodialysis (HD) over the past 8 decades. Reliable, repeatable vascular access for outpatient HD began in the 1960s with the Quinton-Scribner shunt. This was followed by the autologous Brecia-Cimino radial-cephalic arteriovenous fistula (AVF), which dominated HD vascular access for the next 20 years. Delayed referral and the requirement of 1.5-3 months for AVF maturation led to the development of and increasing dependence on synthetic arteriovenous grafts (AVGs) and tunneled central venous catheters, both of which have higher thrombosis and infection risks than AVFs. The use of AVGs and tunneled central venous catheters increased progressively to the point that, in 1997, the first evidence-based clinical practice guidelines for HD vascular access recommended that they only be used if a functioning AVF could not be established. Efforts to promote AVF use in the United States during the past 2 decades doubled their prevalence; however, recent practice guidelines acknowledge that not all patients receiving HD are ideally suited for an AVF. Nonetheless, improved referral for AVF placement before dialysis initiation and improved conversion of failing AVGs to AVFs may increase AVF use among patients in whom they are appropriate.

血液透析血管通路:从历史角度看血管通路的推广、障碍和对未来的启示
本综述介绍了过去八十年血液透析(HD)血管通路的发展历程。用于门诊血液透析的可靠、可重复的血管通路始于 20 世纪 60 年代的 Quinton-Scribner 分流术。随后,自体 Brecia-Cimino 桡-脑动静脉瘘(AVF)问世,并在随后的 20 年中主导了血液透析的血管通路。由于转诊延迟以及动静脉瘘成熟需要 1.5-3 个月的时间,合成动静脉移植物(AVG)和隧道式中心静脉导管应运而生,并日益受到人们的依赖。AVGs 和隧道式中心静脉导管的使用逐渐增加,以至于在 1997 年,第一份以证据为基础的高清血管通路临床实践指南建议,只有在无法建立功能正常的 AVF 时才使用 AVGs 和隧道式中心静脉导管。过去 20 年间,美国为推广 AVF 的使用所做的努力使其普及率翻了一番;然而,最新的实践指南承认,并非所有接受 HD 的患者都适合使用 AVF。尽管如此,在开始透析前转介患者进行 AVF 置入,以及将失效的 AVG 转换为 AVF 的改进措施可能会提高 AVF 在适合患者中的使用率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信